glp-1 heart disease Effects of Receptor Agonists in Failure Patients JCI - Cardioprotective GLP-1 metabolite

Das, S.R., et al., 2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee

About the review The present Review summarizes evidence from major randomized trials and clinical development programs in the field, drawing on literature identified through database searches including PubMed and focusing on key advances reported through October 2025

Tuy nhin, nc da ca bn cng sm mu th cng mt nhiu thi gian da sng/sng hn

Research Protocol Design Considerations The mechanistic differences above translate to distinct research protocol applications

This balanced control over ECM deposition and degradation is critical for its role in promoting healthy tissue architecture rather than fibrotic scar formation